Aurora Cannabis Inc.

Aurora Cannabis Inc.(ACB)の株式分析

$4.170

-0.117 (-2.80%)終値時点

Loading chart…
高値
4.310
始値
4.210
出来高加重平均価格
4.20
出来高
1.19M
時価総額
258.02M
安値
4.130
売買代金
5.02M
EV/EBITDA(TTM)
-6.10

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company operates through its Cannabis segment. The Cannabis segment comprises the Canadian, Europe, Australian and New Zealand CGUs. The Company offers cannabis products including dried flower, pre-rolls, infused pre-rolls, capsules, cannabis oils, concentrates, vapes, edibles, beverages, and topicals. Its brands include Aurora, MedReleaf, Pedanios, San Raf, WMMC, Tasty's, and others. The Company is engaged in distributing wholesale medical cannabis in various international markets, including Australia and New Zealand. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., and ACB Captive Insurance Company Inc., among others.

www.auroramj.com

AI分析 of Aurora Cannabis Inc. (ACB)

買い

Aurora Cannabis Inc is a good buy right now, trading at $4.49, with a recent RSI of 69.36 indicating strong momentum. The stock has seen a 14.54% increase over the past 5 days, suggesting positive short-term momentum. Additionally, the company has a gross margin of 47.68% in its latest quarter, which is significantly higher than previous quarters, indicating improved operational efficiency. However, the main risk is the ongoing hostile takeover bid from Curaleaf, which could lead to volatility in the stock price.

バリュエーション指標

Aurora Cannabis Inc.(ACB)の現在の予想PERは109.89で、5年平均は-47.18です。

予想PER

適正
5年平均 P/E
-47.18
現在のP/E
109.89
割高
306.85
割安
-401.21

予想EV/EBITDA

適正
5年平均 EV/EBITDA
0.15
現在のEV/EBITDA
-6.10
割高
41.60
割安
-41.30

予想PSR

適正
5年平均 P/S
1.72
現在のP/S
0.86
割高
3.23
割安
0.21

Alphio AI による ACB の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%ACB

$8.45

シナリオ価格

基

基本

基本 · 50%ACB

$7.70

シナリオ価格

弱

弱気

弱気 · 25%ACB

$6.10

シナリオ価格

イベントタイムライン

2026-10-14 (ET)

16:00:00

Aurora Cannabis Recommends Shareholders Reject Curaleaf's Acquisition Offer

16:00:00

Aurora Cannabis Explores Alternatives to Surpass Curaleaf's Acquisition Bid

2026-10-08 (ET)

07:30:00

Aurora Cannabis Completes Facility Expansion in Leuna, Germany

2026-10-06 (ET)

17:00:00

Aurora Cannabis Responds to Curaleaf's Takeover Bid

12:00:00

Curaleaf Increases Offer to Acquire Aurora to $6

ニュース

ACB のよくある質問 — Alphio AI が回答

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company operates through its Cannabis segment. The Cannabis segment comprises the Canadian, Europe, Australian and New Zealand CGUs. The Company offers cannabis products including dried flower, pre-rolls, infused pre-rolls, capsules, cannabis oils, concentrates, vapes, edibles, beverages, and topicals. Its brands include Aurora, MedReleaf, Pedanios, San Raf, WMMC, Tasty's, and others. The Company is engaged in distributing wholesale medical cannabis in various international markets, including Australia and New Zealand. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., and ACB Captive Insurance Company Inc., among others. It operates in the Healthcare sector (MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS industry).

Aurora Cannabis Inc is a good buy right now, trading at $4.49, with a recent RSI of 69.36 indicating strong momentum. The stock has seen a 14.54% increase over the past 5 days, suggesting positive short-term momentum. Additionally, the company has a gross margin of 47.68% in its latest quarter, which is significantly higher than previous quarters, indicating improved operational efficiency. However, the main risk is the ongoing hostile takeover bid from Curaleaf, which could lead to volatility in the stock price.

コミュニティ

もっと見る ↗
jadeprism972026/10/5

$ACB Curaleaf is offering about 1.5x sales for this struggling cannabis company. Take the money and shift into the better stock.

もっと見る
登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める